Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.02
-0.14 (-1.67%)
Jun 5, 2025, 4:00 PM - Market closed
Addex Therapeutics Employees
Addex Therapeutics had 2 employees as of December 31, 2024. The number of employees decreased by 21 or -91.30% compared to the previous year.
Employees
2
Change (1Y)
-21
Growth (1Y)
-91.30%
Revenue / Employee
$226,248
Profits / Employee
$3,893,149
Market Cap
6.84M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ADXN News
- 2 days ago - Addex Convenes Annual General Meeting 2025 - GlobeNewsWire
- 24 days ago - Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - GlobeNewsWire
- 5 weeks ago - Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery - GlobeNewsWire
- 5 weeks ago - Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Addex Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 - GlobeNewsWire
- 5 months ago - Addex to Present at the 2025 Swiss Equities Baader Conference - GlobeNewsWire
- 6 months ago - Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Transcript - Seeking Alpha